Immune microenvironment in different molecular subtypes of ductal breast carcinoma Mona SadeghalvadHamid-Reza Mohammadi-MotlaghNima Rezaei Review 03 October 2020 Pages: 261 - 279
Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer Shunchao YanParama DeyBenita S. Katzenellenbogen Preclinical study 01 October 2020 Pages: 281 - 292
The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer Yousif A. KaririMansour AlsaleemEmad A. Rakha Preclinical study Open access 19 October 2020 Pages: 293 - 305
Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments Minami HatonoHirokuni IkedaShinichi Toyooka Preclinical study 09 October 2020 Pages: 307 - 316
Genetic ablation of pregnancy zone protein promotes breast cancer progression by activating TGF-β/SMAD signaling Rohit KumarEkaterina KuliginaSyed K. Hasan Preclinical study 15 October 2020 Pages: 317 - 330
Spindle assembly checkpoint gene BUB1B is essential in breast cancer cell survival Dilara KoyuncuUtsav SharmaMarc E. Lippman Preclinical study 31 October 2020 Pages: 331 - 341
KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer Mei ZhouPrabhakar Pitta VenkataGangadhara R. Sareddy Preclinical study 14 October 2020 Pages: 343 - 357
Patient-reported outcomes among women with unilateral breast cancer undergoing breast conservation versus single or double mastectomy Catherine PesceJennifer JaffeMark Sisco Preclinical study 08 October 2020 Pages: 359 - 369
Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations Yi-Zhou JiangLi-Ping GeZhi-Ming Shao Clinical Trial 25 September 2020 Pages: 371 - 380
The value of mammography in women with focal breast complaints in addition to initial targeted ultrasound L. AppelmanP. T. M. AppelmanR. M. Mann Clinical trial Open access 30 September 2020 Pages: 381 - 389
Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers Lee GalmorRinat Bernstein-MolhoEitan Friedman Clinical trial 30 September 2020 Pages: 391 - 399
Prospective surveillance model in the home for breast cancer-related lymphoedema: a feasibility study Louise A. KoelmeyerEmma MoloneyCatherine M. Dean Clinical trial 01 October 2020 Pages: 401 - 412
Enhanced axillary assessment using intradermally injected microbubbles and contrast-enhanced ultrasound (CEUS) before neoadjuvant systemic therapy (NACT) identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevant Karina CoxNicky DineenAli Sever Clinical trial 07 October 2020 Pages: 413 - 422
Central nervous system metastases in breast cancer: the impact of age on patterns of development and outcome Matan Ben-Zion BerlinerRinat YerushalmiShlomit Yust-Katz Clinical trial 10 October 2020 Pages: 423 - 432
A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients Amit GoyalShama PuriJoanne York Clinical trial 06 October 2020 Pages: 433 - 440
Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study Janine M. SimonsJulien G. JacobsErnest J. T. Luiten Clinical trial Open access 19 October 2020 Pages: 441 - 451
Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention Cynthia Villarreal-GarzaFernanda Mesa-ChavezServando Cardona-Huerta Clinical trial 30 October 2020 Pages: 453 - 458
Effect of level of hormone-receptor expression on treatment outcomes of “triple-positive” early-stage breast cancer Hikmat Abdel-RazeqSara EdailyAyat Taqash Epidemiology 24 September 2020 Pages: 459 - 467
Genetic variants in anti-Müllerian hormone-related genes and breast cancer risk: results from the AMBER consortium Hazel B. NicholsMariaelisa GraffAndrew F. Olshan Epidemiology 22 September 2020 Pages: 469 - 478
Performance of a clinical and imaging-based multivariate model as decision support tool to help save unnecessary surgeries for high-risk breast lesions Dogan S. PolatJennifer G. SchoppBasak E. Dogan Epidemiology 03 October 2020 Pages: 479 - 494
Obesity and breast cancer risk for pre- and postmenopausal women among over 6 million Korean women Jae Won ParkKyungdo HanYong-Moon Park Epidemiology 03 October 2020 Pages: 495 - 506
A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer Christine Brezden-MasleyKelly E. FathersKatarzyna J. Jerzak Epidemiology Open access 16 October 2020 Pages: 507 - 515
Canada follows the US in the rise of bilateral mastectomies for unilateral breast cancer: a 23-year population cohort study L Findlay-ShirrasI LimaA Arnaout Epidemiology 30 October 2020 Pages: 517 - 525
Re: Stage-specific survival has improved for young breast cancer patients since 2000: but not equally? Per-Henrik ZahlIvar Sønbø Kristiansen Letter to the Editor 24 September 2020 Pages: 527 - 528
Comments on patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer Fernando Hernanz Letter to the Editor 24 September 2020 Pages: 529 - 530
Tumor localization for breast cancer patients receiving neoadjuvant chemotherapy Zhen-Yu WuNamkug KimBeomSeok Ko Letter to the Editor 14 October 2020 Pages: 531 - 532